EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The metabolic fate of tritium labeled econazole in man


Xenobiotica 11(9): 595-608
The metabolic fate of tritium labeled econazole in man
Following single oral doses of [3H]econazole base (500 mg) to 2 human subjects, excretion of radioactivity was prolonged and incomplete after 5 days (means of 40 and 27% dose in urine and feces, respectively). Plasma concentration of unchanged econazole and total radioactivity attained peak values at about the same time for each subject (1.5-3 h) but the former declined much faster than the latter. Most of the 3H in early plasma samples was present as unchanged drug and extractable metabolites but after 24 h concentration of econazole were close to the limit of detection (0.04 .mu.g/ml) and very little plasma 3H was extractable, whereas total 3H concentrations were still measurable after 5 days (mean 1.54 .mu.g/ml). Thus, plasma contained metabolites with much longer half-lives than econazole. The main route of biotransformation of econazole in man involved multiple oxidation of the imidazole ring carbons followed by O-dealkylation and conjugation of the resulting alcohols, probably with glucuronic acid.

(PDF 0-2 workdays service: $29.90)

Accession: 006717154



Related references

The metabolic fate of tritium labeled prostaglandin a 1 in the rat and dog. INT UNION PHARMACOL PROCEEDINGS OF THE INTERNATIONAL CONGRESS OF PHARMACOLOGY, 6TH ABSTRACT HELSINKI, FINLAND, 1975 632p ILLUS PERGAMON PRESS: OXFORD, ENGL ; NEW YORK, N Y , USA ISBN 0-08-021308-1 292, 1977

Tritium-labeled dihydromorphine: its metabolic fate and excretion in the rat. Journal of Pharmacology and Experimental Therapeutics 149(3): 446-453, 1965

Adsorption and metabolic fate of dietary tritium labeled squalene in the rat. Lipids 18(3): 233-238, 1983

Tritium labeled di hydro ergocryptine binding to alpha adrenergic receptors of human platelets a reassessment using the selective radio ligands tritium labeled prazosin tritium labeled yohimbine and tritium labeled rauwolscine. Biochemical Pharmacology 31(16): 2591-2598, 1982

The distribution and fate of tritium labeled glucose and tritium labeled galactose in oocytes of oryzias latipes formation of the cortical alveoli. Cell & Tissue Research 209(1): 117-130, 1980

Differential labeling tritium labeled of dopamine receptors in rat brain in vivo comparison of tritium labeled piribedil s tritium labeled 3608 1 coumaran 5 yl methyl 4 2 thiazolyl piperazine hydro chloride and tritium labeled n n propyl norapomorphine. European Journal of Pharmacology 87(1): 85-94, 1983

Metabolic fate of tritium labeled acetophenone derivative of 16 , 17 -dihydroxypro-gesterone. Fed Procpt 1: 462, 1964

Differential labeling of putative skeletal muscle calcium channels by tritium labeled nifedipine tritium labeled nitrendipine tritium labeled nimodipine and tritium labeled pn 200110 iso propyl 4 2 1 3 benzoxadiazol 4 yl 1 4 dihydro 2 6 dimethyl 5 methyoxycarbonyl pyridine 3 carboxylate. Naunyn Schmiedeberg'S Archives Of Pharmacology: 276-277, 1983

Studies on psychotropic drugs. IV. Metabolic fate of tritium labeled Carpipramine in rats. Yakugaku Zasshi 90(2): 204-208, 1970

The metabolic fate of tritium labeled 11 bromo vincamine in rats dogs and humans. Journal of Pharmacobio-Dynamics 5(12): 951-964, 1982